Contact us
OncoNeo400 is a system of AI models built to predict the immunogenicity of MHC, B cells and T cells towards the tumor neoantigens. As an addition OncoNeo400 implements a NetAgent to augment the construction of Antigen, disease and associated proteins knowledge bases using automated mass predictions
Under development
An Ensemble of predictive and causal AI models for Drug discovery. Connecting the dots and finding the hidden patterns trough AI augmentation.
Custom AI solution building as a service
Building Custom AI solutions tailored specifically to Life Science and Business problems
Collaboration
Investors and Companies
Our Case Studies
Examples
Soon…
Glioblastoma AI generated Dataset
Soon…
Advanced Feature Engineering for Drug Discovery
Multimodal AI for Research
Combining Gen AI and Data as a value
- Datasets created using Gen AI
- Accurate synthetic data with its complexity
- AI for Drug Discovery – The data, results and target candidate lists as products
- Feature Engineering – from molecule name to thousands of features for AI projects
- AI for RWE – Data 3D maps using Machine Learning
